Last reviewed · How we verify

NCT06633211

Adjunctive Use of Polynucleotide and Hyaluronic Acid-based Gel in Alveolar Preservation After Tooth Extraction

Not yet recruiting NA Last updated 9 October 2024
What this trial tests

NA trial testing Alveolar ridge preservation using DBBM + Regenfast + collagen matrix in Bone Substitutes in 20 participants. Not yet recruiting.

Timeline
15 October 2024
Primary endpoint
15 October 2025
15 October 2025

Quick facts

Lead sponsorAdrià Jorba García
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment20
Start date15 October 2024
Primary completion15 October 2025
Estimated completion15 October 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Adrià Jorba García

Who can join

18 and older, any sex, with Bone Substitutes or Tooth Extraction Status Nos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alveolar ridge resorption after tooth extraction is a physiological process that continues throughout the patient's life due to the loss of the periodontal ligament and lack of mechanical stimulation. Alveolar ridge preservation (ARP) techniques aim to minimize dimensional changes in the ridge after tooth extraction. These techniques involve grafting the socket to fill the bed and/or sealing it with a biomaterial. Currently, there is a polynucleotide and hyaluronic acid-based gel (Regenfast®) on the market that has proven useful in treating residual periodontal defects. Hyaluronic acid-based gels also appear to enhance the regenerative potential of critical bone defects in both in-vitro studies on rats and clinical studies. Therefore, this study aims to evaluate the clinical and histological effects of polynucleotide and hyaluronic acid-based gel in alveolar preservation procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Adrià Jorba García trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06633211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing